STOCK TITAN
  1. Home
  2. News
  3. MMSI

Merit Medical Systems, Inc. - MMSI STOCK NEWS

Welcome to our dedicated news page for Merit Medical Systems (Ticker: MMSI), a resource for investors and traders seeking the latest updates and insights on Merit Medical Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Merit Medical Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Merit Medical Systems's position in the market.

News
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
Rhea-AI Summary
Merit Medical Systems, Inc. announces the commercial release of its FDA-cleared Micro ACE Advanced Micro-Access System, designed to achieve successful micro-access in challenging cases. The system offers improved stiffness and resiliency over competitors, enhancing visibility and accuracy during interventional procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
none
-
News
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
Rhea-AI Summary
Merit Medical Systems, Inc. (MMSI) will release its financial results for Q1 2024 on April 30, 2024, followed by an investor conference call. The call will take place at 5:00 p.m. Eastern. Access details can be found on merit.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
earnings
-
News
Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) will host educational events for clinicians attending the 2024 SIR Annual Meeting at their Salt Lake City headquarters and SIR booth 320. The Evening of Innovation on March 26 will feature talks by Chairman and CEO Fred Lampropoulos, a reception, facility tour, and hands-on learning opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
conferences
News
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
Rhea-AI Summary
Merit Medical Systems, Inc. reported revenue of $324.5 million for Q4 2023, showing a 10.6% increase year-over-year. The company also achieved an 8.3% growth in constant currency revenue. Merit's GAAP operating margin was 10.4%, with a non-GAAP operating margin of 18.2%. The GAAP EPS was $0.47, while the non-GAAP EPS stood at $0.81. The company introduced financial guidance for fiscal year 2024, highlighting stable growth and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
earnings
-
News
Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
Rhea-AI Summary
Merit Medical Systems, Inc. introduces Continued Growth Initiatives Program with financial targets for the three-year period ending December 31, 2026. Targets include 5-7% organic revenue growth, 20-22% non-GAAP operating margin, and $400 million cumulative free cash flow generation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
none
-
News
Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System
Rhea-AI Summary
Merit Medical Systems, Inc. (MMSI) receives FDA clearance for SCOUT MD Surgical Guidance System, a breakthrough in breast cancer care. The system targets tumor location in multiple dimensions for precise excision, reducing the need for repeat surgeries and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
clinical trial
News
First Patient Enrolled in Merit Medical’s MOTION Study
Rhea-AI Summary
Merit Medical Systems, Inc. announces the enrollment of the first patient in its multicenter clinical trial comparing genicular artery embolization (GAE) to corticosteroid injections for knee osteoarthritis. The MOTION study aims to evaluate the safety and effectiveness of Embosphere Microspheres for pain relief, with the potential to set a new standard in knee-pain management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
-
News
Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024
Rhea-AI Summary
Merit Medical Systems, projected a preliminary unaudited revenue of approximately $1.255 to $1.259 billion for the year ended December 31, 2023, showing a projected increase of approximately 9.0% to 9.4% compared to the previous year. The projected preliminary unaudited constant currency revenue for the same period increased in the range of approximately 9.6% to 9.9%. The company plans to announce its financial results for the fourth quarter and year ended December 31, 2023, and issue fiscal year 2024 guidance after the close of the stock market on Wednesday, February 28, 2024. The company's ticker symbol is MMSI.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
earnings
-
News
Merit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference
Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) Chairman and CEO Fred Lampropoulos will present at the J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024, at 4:30pm PT. The company's live audio webcast will be available on the investor section of the Merit Medical website www.merit.com. Mr. Lampropoulos expressed excitement to share the company's mission of product innovation to improve patients' lives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
conferences
News
Merit Medical Announces Process for Chief Executive Officer Succession Planning
Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) outlines the CEO succession planning process, with Fred Lampropoulos continuing as CEO and President through December 31, 2025. A special steering committee is developing a succession plan, with Korn Ferry assisting in identifying potential candidates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
Stock MMSI logo
Merit Medical Systems, Inc.

Nasdaq:MMSI

MMSI Rankings

#1296 Ranked by Market Cap
#1973 Ranked by Stock Gains
N/A Ranked by Dividends

MMSI Stock Data

4.22B
56.54M
2.44%
101.72%
3.41%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
South Jordan

About MMSI

merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c